在患有自身免疫性肝病的患者中选择性免疫球蛋白M缺乏症
Yasemin H Balaban1, Mohamed İsmail2, Şefika Nur Ayar3
1Division of Gastroenterology, Department of Internal Medicine, Hacettepe University Medical Faculty, Ankara, Türkiye.
概括
选择性免疫球蛋白M缺乏与自身免疫性肝脏疾病有关. 这一发现可能会影响这些疾病的诊断和治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 肝病学 肝病学是一种肝病学.
- 胃肠病学 胃肠病学
背景情况:
- 自免疫性肝病 (ALD) 包含一组慢性肝病,其特点是免疫系统攻击肝细胞.
- 免疫球蛋白M (IgM) 在适应性免疫反应中起着至关重要的作用.
- 特定免疫球蛋白 (如IgM) 的缺陷可能与各种免疫失调和临床结果有关.
研究的目的:
- 研究被诊断患有自身免疫性肝病的患者选择性免疫球蛋白M (sIgM) 缺乏症的患病率和临床意义.
- 确定sIgM缺陷与ALD的特定类型或疾病活性之间的潜在相关性.
主要方法:
- 对患者数据的回顾性分析,包括自身免疫性肝病诊断.
- 在患者队列中测量血清免疫球蛋白水平,特别关注IgM.
- 在ALD患者和对照组之间的sIgM水平的比较,如果适用.
主要成果:
- 患有自身免疫性肝病的患者中很大一部分患者表现出选择性免疫球蛋白M缺乏.
- 初步发现表明,sIgM缺乏症与某些自身免疫性肝病表型之间存在潜在的关联.
结论:
- 选择性免疫球蛋白M缺乏可能是自身免疫性肝病的病理生理学或临床表现的一个未被认可的因素.
- 需要进一步的研究来阐明SIGM缺乏在ALD管理中的因果关系和临床影响.
相关概念视频
Immunodeficiency Diseases
928
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
928
Transcytosis of IgG
2.7K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.7K
Development of Immunocompetence
296
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
296


